Covid: In the face of opposition, Taiwan introduces a homegrown vaccine

Taiwan has begun delivering the Covid-19 vaccine, which was created domestically, despite accusations that its clearance was hurried.

Vaccination efforts in Taiwan have been impeded by delivery delays and public scepticism.

On Monday, President Tsai Ing-wen was the first to receive the Medigen vaccine.

There were no serious safety issues, according to the business, and studies revealed that the antibodies produced were “no worse” than those produced by AstraZeneca’s vaccination.

Later this year, it is planned to complete the final phase of trials in Paraguay.

Medigen is a recombinant protein vaccine similar to Novavax’s vaccine. Its Chinese name literally means “high-end.”

In the United Kingdom, the Novavax Covid jab has an efficacy rate of 89 percent. ” We’ve done so many experiments that everyone can see how safe our vaccine is, “says the researcher. There are very few negative effects, such as a lack of fever. As a result, I believe everyone can relax. ” According to Reuters, Medigen’s Chief Executive Officer, Charles Chen.

However, charges that the vaccine is hazardous or that its introduction onto the market was rushed have dogged its deployment, with many coming from Taiwan’s largest opposition party, the Kuomintang (KMT).

Due to insufficient testing, two key members of the party petitioned the court to rescind the emergency use permit.

Taiwan has been utilizing Modern and AstraZeneca vaccinations, but President Tsai waited until the Medigen vaccine was ready before getting her dose.

Her getting of the injection was streamed live on her Facebook page, and when asked if she was nervous, she said “no.”

Over 700,000 people have already signed up for the Medigen vaccine, which is administered in two doses separated by 28 days.

The government has ordered five million doses, but no one will be forced to acquire the vaccine, according to the administration.

Only about 5% of Taiwan’s 23.5 million people are fully vaccinated, with roughly 40% having received only one shot.